Genetic risk and protective factors of TNFSF15 gene variants detected using single nucleotide polymorphisms in Hungarians with psoriasis and psoriatic arthritis

Human Immunology

Volumn 75, Issue 2, 2014, Pages 159-162

  Képíró, László ^a   Széll, Márta ^a   Kovács, László ^a   Keszthelyi, Péter ^b   Kemény, Lajos ^a   Gyulai, Rolland ^a,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Pandy Kalman Bekes County Hospital   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; TNFSF15 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUNGARY; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT; CHILD; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; RISK FACTOR; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; CHILD; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HUNGARY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RISK FACTORS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; YOUNG ADULT;

EID: 84892371734     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.11.006     Document Type: Article

References (28)

1. Griffiths C.E., Baker J.N. Pathogenesis and clinical feathers of psoriasis. Lancet 2007, 370:263-271.
2. Nickoloff B.J., Nestle F.O. Recent insight into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004, 113:1664-1675.
3. Gladman D., Antoni C., Mease P., Clegg D.O., Nash P. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis 2005, 64(Suppl. 2):ii14-ii17.
4. Sheeb M., Uramoto K.M., Gibson L.E., O'Fallon W.M., Gabriel S.E. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000, 27:1247-1250.
5. Gladman D.D., Anhorn K.A., Schachter R.K., Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986, 13:586-592.
6. Nickoloff B.J. The cytokine network in psoriasis. Arch Dermatol 1991, 127:871-884.
7. Veale D.J., Ritchlin C., Fitzgerald O. Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005, 64:26-29.
8. Yue T.L., Ni J., Romanic A.M., Gu J.L., Keller P., Wang C., et al. TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J Biol Chem 1999, 274:1479-1486.
9. Zhai Y., Ni J., Jiang G.W., Lu J., Xing L., Lincoln C., et al. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J 1999, 13:181-189.
10. Migone T.S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479-492.
11. Zhang Z., Li L.Y. TNFSF15 modulates neovascularization and inflammation. Cancer Microenviron 2012, 5(3):237-247.
12. Thiébaut R., Kotti S., Jung C., Merlin F., Colombel J.F., Lemann M., et al. TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. Am J Gastroenterol 2009, 104(2):384-391.
13. Kang Y.J., Kim W.J., Bae H.U., Kim D.I., Park Y.B., Park J.E., et al. Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine 2005, 29(5):229-235.
14. Cassatella M.A., Pereira-da-Silva G., Tinazzi I., Facchetti F., Scapini P., Calzetti F., et al. Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol 2007, 178(11):7325-7333.
15. Bamias G., Evangelou K., Vergou T., Tsimaratou K., Kaltsa G., Antoniou C., et al. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Exp Dermatol 2011, 20(9):725-731.
16. Bamias G., Martin C., Marini M., Hoang S., Mishina M., Ross W.G., et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 2003, 171(9):4868-4874.
17. Picornell Y., Mei L., Taylor K., Yang H., Targan S.R., Rotter J.I. TNFSF15 is an ethnic-specific IBD gene. Inflamm Bowel Dis 2007, 13(11):1333-1338.
18. Helliwell P., Taylor W. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005, 64(Suppl. 2):ii3-ii8.
19. Yang S.K., Lim J., Chang H.S., Lee I., Li Y., Liu J., et al. Association of TNFSF15 with Crohn's disease in Koreans. Am J Gastroenterol 2008, 103(6):1437-1442.
20. Yamazaki K., McGovern D., Ragoussis J., Paolucci M., Butler H., Jewell D., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005, 14(22):3499-3506.
21. Kamada N., Hisamatsu T., Honda H., Kobayashi T., Chinen H., Takayama T., et al. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm Bowel Dis 2010, 16(4):568-575.
22. Pappu B.P., Borodovsky A., Zheng T.S., Yang X., Wu P., Dong X., et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J Exp Med 2008, 205(5):1049-1062.
23. Bebes A., Német I.B., Vas K., Bata-Csörgo Z., Kemény L., Tubak V. The soluble form of TL1A cytokine produced by human keratinocytes may contribute to psoriasis pathogenesis. J Invest Dermatol 2012, 132(2):S1-161.
24. Bernstein C.N., Wajda A., Blanchard J.F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005, 129(3):827-836.
25. Weng X., Liu L., Barcellos L.F., Allison J.E., Herrinton L.J. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Am J Gastroenterol 2007, 102(7):1429-1435.
26. Yates V.M., Watkinson G., Kelman A. Further evidence for an association between psoriasis, Crohn' disease and ulcerative colitis. Br J Dermatol 1982, 106(3):323-330.
27. Safrany E., Szabo M., Szell M., Kemeny L., Sumegi K., Melegh B.I., et al. Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis. Inflamm Res 2013, 62(2):195-200.
28. Cargill M., Schrodi S.J., Chang M., Garcia V.E., Brandon R., Callis K.P., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007, 80(2):273-290.